OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2021
(2)
2025
(1)
2020
(1)
2019
(1)
2016
(1)
2012
(1)
2003
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Not available
S-EPMC1885458
|
biostudies-literature
Cite
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Not available
S-EPMC4989198
|
biostudies-literature
Cite
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Not available
S-EPMC6587727
|
biostudies-literature
Cite
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.
Not available
S-EPMC11987804
|
biostudies-literature
Cite
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Not available
S-EPMC8345200
|
biostudies-literature
Cite
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Not available
S-EPMC8336294
|
biostudies-literature
Cite
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
Not available
S-EPMC3435441
|
biostudies-literature
Cite
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
Not available
S-EPMC6974400
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets